DRAK2 anticorps (AA 251-300)
Aperçu rapide pour DRAK2 anticorps (AA 251-300) (ABIN1452072)
Antigène
Voir toutes DRAK2 (STK17B) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 251-300
-
Specificité
-
STK17B Antibody detects endogenous levels of STK17B.
-
Purification
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
-
Immunogène
- The antiserum was produced against synthesized peptide derived from human STK17B.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Stable at -20°C for at least 1 year.
-
-
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
Autre désignation
- STK17B
-
Sujet
-
Synonyms: Serine/threonine-protein kinase 17B, DAP kinase-related apoptosis-inducing protein kinase 2, STK17B, DRAK2
NCBI Gene Symbol: STK17B
-
Poids moléculaire
- 42 kDa
-
ID gène
- 9262
-
OMIM
- 604727
-
UniProt
- O94768
Antigène
-